Events
C5Research at AHA 09
Tuesday, Nov 17, 2009
Clinical Predictors of Atherosclerosis Progression in Patients With Very Low Levels of LDL Cholesterol
Ozgur Bayturan, Stephen J Nicholls, Mingyuan Shao, Kiyoko Uno, Ajai Shreevatsa, Andrea Lavoie, Kathy Wolski, Paul Schoenhagen, E Murat Tuzcu, Steven E Nissen, Samir Kapadia, Cleveland Clinic, Cleveland, OH
2:30 PM - 2:45 PM, Room W314a
Wednesday, Nov 18, 2009
Application of the Seattle Heart Failure Model to Patients Presented to a Heart Transplant Committee
Eiran Z Gorodeski, Cleveland Clinic, Cleveland, OH; Eric C Chu, Case Western Reserve Univ Sch of Med, Cleveland, OH; Chen H Chow, Univ Hosp of Cleveland, Cleveland, OH; Wayne C Levy, Univ of Washington, Seattle, WA; Eileen Hsich, Randall C Starling, Cleveland Clinic, Cleveland, OH
2:15 PM - 2:30 PM, Room W101
Elevated Plasma Myleoperoxidase as Indicator for Vulnerable Plaque in Stable Patients With Diabetes Mellitus
W. H. Wilson Tang, Stephen J Nicholls, Danielle M Brennan, Stanley L Hazen, Cleveland Clinic, Cleveland, OH
3:45 PM - 4:00 PM, Room W314a
Transvenous Pacemaker and Defibrillator Lead Extraction in the Setting of Noninfectious Indications: A Large, Single Center Experience
Timothy H Mahoney, Carlos Alves, Ousamma Wazni, David O Martin, Walid Saliba, Mark Niebauer, Niraj Varma, Thomas Callahan, Mohamed Kanj, Bruce L Wilkoff, Cleveland Clinic, Cleveland, OH
3:00 PM - 3:15 PM, Room W230ab
Sunday, Nov 15, 2009, 9:30 AM -11:00 AM
Aleglitazar, a Balanced Peroxisome Proliferator-Activated Receptor (PPAR)α/γ Agonist, Provides Beneficial Effects on Cardiovascular Markers of Inflammation and Clotting
Robert R Henry, Univ of California at San Diego, San Diego, CA;
A. Michael Lincoff, Cleveland Clinic, Cleveland, OH; Sunder Mudaliar, Univ of California at San Diego, San Diego, CA; Cathy Chognot, F. Hoffmann-La Roche AG, Basel, Switzerland; Michael Rabbia, Hoffmann-La Roche Inc., Nutley, NJ; Matthias Herz, F. Hoffmann-La Roche AG, Basel, Switzerland
Poster Hall A2-A3, Core 2, Poster Board: 2024